CAR T cell therapy has shown remarkable success in treating blood cancers, but current production methods using viral vectors are extremely expensive, limiting patient access. In this groundbreaking study, researchers…
Read More
Touchlight Wins ISPE Facility of the Year Award for Innovation, Recognised for Revolutionary dbDNA™ Manufacturing at Morelands Facility Published: 12 May 2025Touchlight, a pioneering leader in synthetic DNA technology, is…
Read More
Within advanced therapy manufacturing, more and more companies are turning to enzymatically produced DNA as an alternative to plasmid DNA.
Read More
Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms Published: 27 January 2025 Touchlight Genetics, in partnership with the National Physical Laboratory (NPL)…
Read More
Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health Published: 16 January 2025 Ceva and Touchlight entered into an agreement and a long-term…
Read More
Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA Published: 14 January 2025 Touchlight’s dbDNA technology is the first synthetic DNA technology to receive a GMP certificate globally Touchlight…
Read More
As advanced therapies continue to transform the healthcare landscape, the need for sustainable manufacturing solutions grows more critical. Traditional plasmid DNA (pDNA) production presents costly, resource-intensive challenges, threatening scalability and…
Read More
Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery Published: 14 November 2024 Lisa Caproni, Ph.D. As gene therapy continues to evolve, nonviral DNA delivery is rapidly gaining traction…
Read More
ELENA STOYANOVA, PH.D. & TOM ADIE, PH.D. Touchlight is at the forefront of innovation in gene editing technology with our groundbreaking MegaBulb DNA (mbDNA). This novel, circular, single-stranded DNA template…
Read More
Touchlight to supply GMP dbDNA to support University of Nottingham’s clinical study for a next-generation vaccine for Zika virus Published: 21 August 2024 Touchlight, an innovation-driven contract development and manufacturing…
Read More
